𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled Growth Factor Delivery for Tissue Engineering

✍ Scribed by Prakriti Tayalia; David J. Mooney


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
526 KB
Volume
21
Category
Article
ISSN
0935-9648

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Controlled release scaffolds for bone ti
✍ Sarah Cartmell πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 143 KB

Bone disease and trauma can sometimes create defects that require more than current clinical therapies can provide for effective healing. Scaffolds that release bioactive agents such as drugs offer additional benefits in this regard in comparison to those whose main requirements are space filling an

Hydrogels for tissue engineering and del
✍ Biancamaria Baroli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 417 KB

This manuscript presents hydrogels (HGs) from a tissue engineering perspective being especially written for those who are approaching this field by offering a concise but inclusive review of hydrogel synthesis, properties, characterization methods, and applications.

Aerosol delivery of mammalian cells for
✍ Andrew Roberts; Barbara E. Wyslouzil; Lawrence Bonassar πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 252 KB

## Abstract We developed a two fluid atomizer to spray mammalian cells suspended in phosphate buffered saline (PBS)–Pluronic F‐127 polymer solutions. We used the device to spray suspensions of bovine articular chondrocytes and porcine tracheal epithelial cells, in either PBS or the polymer solution

Controlled delivery of platelet-rich pla
✍ Helen H. Lu; Jennifer M. Vo; Hsin Sheila Chin; Jeffrey Lin; Matthew Cozin; Rick πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 343 KB πŸ‘ 1 views

## Abstract Platelet‐rich plasma (PRP) represents an autologous source of growth factors essential for bone regeneration. The clinical efficacy of PRP is, however, unpredictable, and this is likely due to the inefficient and inconsistent delivery of PRP‐derived growth factors. Previous investigatio